Pharma-Bio Serv, Inc. PBSV
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.58M | 8.47M | 10.56M | 10.85M | 10.73M |
| Total Receivables | 2.42M | 2.72M | 2.65M | 2.36M | 2.02M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 240.20K | 90.60K | 109.10K | 171.60K | 415.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 11.24M | 11.29M | 13.32M | 13.39M | 13.16M |
|
|
|||||
| Total Current Assets | 11.24M | 11.29M | 13.32M | 13.39M | 13.16M |
| Net Property, Plant & Equipment | 80.10K | 92.40K | 103.70K | 145.40K | 204.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 120.80K | 120.80K | 120.80K | 120.80K | 225.60K |
| Total Assets | 11.44M | 11.50M | 13.55M | 13.65M | 13.59M |
|
|
|||||
| Total Accounts Payable | 929.60K | 978.50K | 870.00K | 991.20K | 874.40K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 28.80K | 71.40K |
| Total Finance Division Other Current Liabilities | 65.20K | 66.60K | 2.44M | 718.80K | 713.20K |
| Total Other Current Liabilities | 65.20K | 66.60K | 2.44M | 718.80K | 713.20K |
| Total Current Liabilities | 994.70K | 1.05M | 3.31M | 1.74M | 1.66M |
|
|
|||||
| Total Current Liabilities | 994.70K | 1.05M | 3.31M | 1.74M | 1.66M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 994.70K | 1.05M | 3.31M | 1.74M | 1.66M |
|
|
|||||
| Common Stock & APIC | 1.71M | 1.70M | 1.69M | 1.68M | 1.68M |
| Retained Earnings | 9.07M | 9.08M | 8.85M | 10.53M | 10.53M |
| Treasury Stock & Other | -330.40K | -326.70K | -300.60K | -301.20K | -284.50K |
| Total Common Equity | 10.44M | 10.45M | 10.24M | 11.91M | 11.93M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.44M | 10.45M | 10.24M | 11.91M | 11.93M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.44M | 10.45M | 10.24M | 11.91M | 11.93M |
|
|
|||||